Next-Gen Paradigm Insulin Pump Will Incorporate MiniMed Glucose Sensor

Medtronic MiniMed plans to begin a prospective, randomized, multi-center clinical trial this fall to support a PMA filing for the Paradigm 522/722 sensor-augmented insulin pump system

More from Archive

More from Medtech Insight